gastric cancer, colorectal cancer, esophageal cancer, esophageal achalasia
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) patients who undergo endoscopic operation 2) written informed concent
Exclusion criteria
Exclusion criteria: patients who have a history of liver cirrhosis, are undergoing artificial dialysis, have other malignancies, and are using immunomodulatory drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| changes in serum opsonic activity on the next day and at 4 days after endoscopic operation | — |
Countries
Japan
Contacts
Hirosaki University Graduate School of Medicine Department of Gastroenterology, Hematology and Clinical immunology